Literature DB >> 16705640

Three-dimensional modeling of cytomegalovirus DNA polymerase and preliminary analysis of drug resistance.

Rong Shi1, Arezki Azzi, Christian Gilbert, Guy Boivin, Sheng-Xiang Lin.   

Abstract

Cytomegalovirus (CMV) is the leading cause of congenital infection and a frequent opportunistic agent in immunocompromised hosts such as transplant recipients and AIDS patients. CMV DNA polymerase, a member of the polymerase B family, is the primary target of all available antivirals (ganciclovir, cidofovir, and foscarnet) and certain variations of this enzyme could lead to drug resistance. However, understanding the drug resistance mechanisms at the atomic level is hampered by the lack of its three-dimensional (3D) structure. In the present work, 3D models of two different conformations (closed and open) for CMV DNA polymerase have been built based on the crystal structures of bacteriophage RB69 DNA polymerase (a member of the polymerase B family) by using the 3D-Jury Meta server and the program MODELLER. Most of the variations on CMV DNA polymerase pertinent to ganciclovir/cidofovir and foscarnet resistance can be explained well based on the open and closed conformation models, respectively. These results constitute a first step towards facilitating our understanding of drug resistance mechanisms for CMV and the interpretation of novel viral mutations. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705640     DOI: 10.1002/prot.21005

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  11 in total

1.  Characterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54.

Authors:  Frédéric Picard-Jean; Isabelle Bougie; Martin Bisaillon
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

2.  Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.

Authors:  Egor P Tchesnokov; Aleksandr Obikhod; Raymond F Schinazi; Matthias Götte
Journal:  J Biol Chem       Date:  2009-07-21       Impact factor: 5.157

3.  Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.

Authors:  Scott H James; Nathan B Price; Caroll B Hartline; E Randall Lanier; Mark N Prichard
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

4.  Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet.

Authors:  Christian Gilbert; Arezki Azzi; Nathalie Goyette; Sheng-Xiang Lin; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

5.  Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase.

Authors:  Karl E Zahn; Egor P Tchesnokov; Matthias Götte; Sylvie Doublié
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

6.  Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis.

Authors:  Jocelyne Piret; Manuel Schibler; Van Dung Pham; Sébastien Hantz; Federica Giannotti; Stavroula Masouridi-Levrat; Laurent Kaiser; Nathalie Goyette; Sophie Alain; Rong Shi; Guy Boivin
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

7.  In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.

Authors:  G Andrei; D Topalis; P Fiten; C McGuigan; J Balzarini; G Opdenakker; R Snoeck
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

8.  Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.

Authors:  Jocelyne Piret; Nathalie Goyette; Brian E Eckenroth; Emilien Drouot; Matthias Götte; Guy Boivin
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

9.  Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene.

Authors:  Sunwen Chou
Journal:  Antiviral Res       Date:  2016-12-08       Impact factor: 5.970

10.  Fluorescence-based assay for phenotypic characterization of human cytomegalovirus polymerase mutations regarding drug susceptibility and viral replicative fitness.

Authors:  Meike Chevillotte; Axel Schubert; Thomas Mertens; Jens von Einem
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.